AQR Arbitrage’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

AQR Arbitrage’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-86,040	Closed	-$1.83M	–	630
2024 Q1	$1.83M	Buy	+86,040	New	+$1.03M	0.06%	243

AQR Arbitrage's FUSN Position: Q2 2024 in Review

AQR Arbitrage sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 86,040 shares — an estimated $1.83M sold.

AQR Arbitrage first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $1.83M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

AQR Arbitrage reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
AQR Arbitrage sold 86,040 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $1.83M.
AQR Arbitrage first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
AQR Arbitrage's Fusion Pharmaceuticals Inc. Common Shares position peaked at $1.83M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on AQR Arbitrage's 13F filing for Q2 2024, filed 14 Aug 2024.